Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma
T. Schneeberger (Marburg, Germany), J. Gebhardt (Marburg, Germany), I. Jarosch (Marburg, Germany), R. Gloeckl (Munich, Germany), M. Boensch (Marburg, Germany), C. Taube (Essen, Germany), K. Kenn (Marburg, Germany), R. Koczulla (Marburg, Germany)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Session: Hot topics in pulmonary rehabilitation
Session type: Poster Discussion
Number: 3415
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Schneeberger (Marburg, Germany), J. Gebhardt (Marburg, Germany), I. Jarosch (Marburg, Germany), R. Gloeckl (Munich, Germany), M. Boensch (Marburg, Germany), C. Taube (Essen, Germany), K. Kenn (Marburg, Germany), R. Koczulla (Marburg, Germany). Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma. 3415
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Long-term benefits of pulmonary rehabilitation in patients with chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002
Effects of pulmonary rehabilitation in asthma patients Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Effects of pulmonary rehabilitation in patients with asthma Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018
Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021
Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with TDI-induced asthma Source: Eur Respir J 2005; 26: Suppl. 49, 604s Year: 2005
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Effect of asthma and asthma medication on the prognosis of patients with COVID-19 Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020 Year: 2021
Comparing the effects of pulmonary rehabilitation in patients with uncontrolled and partially controlled asthma Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018
Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 267s Year: 2001
Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 546s Year: 2007
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005
Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Benefits of pulmonary rehabilitation program in patients with persistent asthma Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Effects of exercise in patients with moderate to severe asthma Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Effects of pulmonary rehabilitation in the management of moderate COPD adults Source: Eur Respir J 2004; 24: Suppl. 48, 518s Year: 2004
Evaluating the efficacy of omalizumab in severe persistent asthma patients Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012